Safe Orthopaedics Statistics
Total Valuation
EPA:ALSAF has a market cap or net worth of EUR 218,935. The enterprise value is 199.82 million.
Market Cap | 218,935 |
Enterprise Value | 199.82M |
Important Dates
The last earnings date was Thursday, July 10, 2025.
Earnings Date | Jul 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
EPA:ALSAF has 91,223 shares outstanding.
Current Share Class | 91,223 |
Shares Outstanding | 91,223 |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.04 |
PB Ratio | -0.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.97 |
EV / Sales | 34.39 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -167.64 |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | -227.52 |
Interest Coverage | -28.37 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -8.19% |
Return on Invested Capital (ROIC) | -9.98% |
Return on Capital Employed (ROCE) | 3.13% |
Revenue Per Employee | 60,521 |
Profits Per Employee | -2.14M |
Employee Count | 96 |
Asset Turnover | 0.12 |
Inventory Turnover | 0.36 |
Taxes
Income Tax | -65.87M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -96.00% in the last 52 weeks. The beta is 0.33, so EPA:ALSAF's price volatility has been lower than the market average.
Beta (5Y) | 0.33 |
52-Week Price Change | -96.00% |
50-Day Moving Average | 2.64 |
200-Day Moving Average | 59.97 |
Relative Strength Index (RSI) | 41.43 |
Average Volume (20 Days) | 26,237,223 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, EPA:ALSAF had revenue of EUR 5.81 million and -205.44 million in losses.
Revenue | 5.81M |
Gross Profit | 4.22M |
Operating Income | -6.19M |
Pretax Income | -271.32M |
Net Income | -205.44M |
EBITDA | -5.34M |
EBIT | -6.19M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 780,000 in cash and 271.21 million in debt, giving a net cash position of -270.43 million or -2,964.44 per share.
Cash & Cash Equivalents | 780,000 |
Total Debt | 271.21M |
Net Cash | -270.43M |
Net Cash Per Share | -2,964.44 |
Equity (Book Value) | -202.35M |
Book Value Per Share | n/a |
Working Capital | -266.78M |
Cash Flow
In the last 12 months, operating cash flow was -1.14 million and capital expenditures -56,000, giving a free cash flow of -1.19 million.
Operating Cash Flow | -1.14M |
Capital Expenditures | -56,000 |
Free Cash Flow | -1.19M |
FCF Per Share | -13.07 |
Margins
Gross Margin | 72.70% |
Operating Margin | -106.45% |
Pretax Margin | -4,669.81% |
Profit Margin | n/a |
EBITDA Margin | -91.94% |
EBIT Margin | -106.45% |
FCF Margin | n/a |
Dividends & Yields
EPA:ALSAF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -93,837.90% |
FCF Yield | -544.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 0.001.
Last Split Date | Jul 7, 2025 |
Split Type | Reverse |
Split Ratio | 0.001 |
Scores
EPA:ALSAF has an Altman Z-Score of -7.99 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -7.99 |
Piotroski F-Score | 3 |